Cocrystal patent

Author: tvaf

August undefined, 2024

WebNov 1, 2024 · BOTHELL, Wash., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Cocrystal … WebA pharmaceutical composition comprising a co-crystal of an API and a co-crystal former; wherein the API has at least one functional group selected from ether, thioether, alcohol, thiol, aldehyde, ketone, thioketone, nitrate ester, phosphate ester, thiophosphate ester, … Us20070026078a1 - US7927613B2 - Pharmaceutical co-crystal compositions …

US Patent Application for PROCESS FOR PRODUCING …

WebMar 8, 2024 · Structural Database and cocrystal relate d patent applications. Considering this, it i s surprising that cocrystal preparation methods have remained, until relatively r ecently, largely poorly ... WebAug 10, 2024 · Research in cocrystal structure and applications has shown an exponential increase in the past decade, evident in the number of cocrystal structures deposited in the Cambridge Structural Database and cocrystal related patent applications. In light of this, it is surprising that cocrystal preparation methods have remained, until relatively ... helm hook annotations

Cocrystal Screening, Selection, Formulation at Triclinic Labs

WebCocrystal publications from 2001 to 2024 generated from a search of the Web of Science ® database for terms ‘cocrystal’ OR ‘co-crystal’ NOT ‘structural biology’ NOT ‘structural basis’ (13 August 2024) (black bars) versus number of cocrystal patents from 2001 to 2024 generated from a search of the US Patent and Trademark Office ... WebAug 18, 2016 · Now suppose NewCo, in addition to the patent on the API drug substance, also patents the API-succinic acid cocrystal and shows it to be bioequivalent to the API. In that case, NewCo would be able ... WebThe cocrystal of claim 3 wherein the coformer is benzoic acid and the ratio of progesterone to benzoic acid is 2:1 and the cocrystal is a hemihydrate. 8 . The cocrystal of claim 7 having an x-ray powder diffraction pattern having one or more peaks selected from about 8.1, 12.3, 13.8, 14.4, 16.9, 18.0, 20.7, or 21.1 °2θ. la law organized crime

Oxaliplatin-flavone pharmaceutical co-crystal-CN111205332A: …

Cocrystal of c-glycoside derivative and l-proline - Patent WO ...

WebThis disclosure features chemical entities (e.g., a compound exhibiting activity as a mitochondrial uncoupling agent or a pharmaceutically acceptable salt and/or hydrate and/or cocrystal thereof; e.g., a compound, such as niclosamide or a pharmaceutically acceptable salt and/or hydrate and/or cocrystal thereof; e.g., a compound, such as a niclosamide … WebA water-soluble aspirin, citric acid, sodium bicarbonate, L-theanine cocrystal composition which includes a quantity of acetylsalicylic acid is described. The composition may be created by a method including various steps, including a cocrystallization step. The water-soluble cocrystal composition is suitable for sublingual administration, preferably to … helm honda trxWebThe number of cocrystal-related patent submissions surged by seven-fold throughout 2004 to 2016. 9 As intellectual property, pharmaceutical cocrystals generate ample opportunities for inventors to extend the drug lifecycle. 9,10 Recent revision in the FDA regulatory guideline of pharmaceutical cocrystals for the industry, ... helm hoplit

"Webcocrystal theta degrees radiation proline Prior art date 2024-10-31 Application number PCT/EP2024/079899 Other languages French (fr) Inventor Nicolas Tesson ... 2024-10-31 Priority to EP19801242.9A priority patent/EP3873459A1/en 2024-10-31 Priority to US17/286,949 priority patent/US20240380514A1/en " - Cocrystal patent

Cocrystal patent

Creating Cocrystals: A Review of Pharmaceutical Cocrystal …

WebApr 6, 2024 · Cocrystal Pharma Granted European Patent Covering Oral Antiviral Candidate CC-42344 in Combination with Another Antiviral Agent for the Treatment of Influenza October 26, 2024 it.tmcnet.com Enrollment Completed in Phase 1 Influenza A Study with Cocrystal Pharma's Oral Antiviral Candidate CC-42344 WebApr 9, 2024 · X-ray powder diffraction is a vital analytical tool that is used in pharmaceutical science. It is increasingly used to establish the crystal structure of a new pharmaceutical substance, in particular, cocrystal or its polymorphic forms. This review begins with a brief discussion of the reliability of the structural parameters retrieved from powder patterns. …

Did you know?

WebThe present invention is to provide a novel cocrystal form using sacubitril calcium salt, … WebExamples of Cocrystal Patent Rights in a sentence. The Parties agree to cooperate fully …

WebAug 6, 2009 · The invention relates to crystalline forms of flupirtine, particularly to 1:1 flupirtine hydrochloride maleic acid cocrystal. The preparation and characterization of 1:1 flupirtine hydrochloride maleic acid cocrystal is described. The invention also relates to the therapeutic use of the flupirtine hydrochloride maleic acid cocrystal to treat … WebFeb 28, 2024 · An amount of protein complex determined in the presence of the medicament less than the first determined amount indicates a favorable treatment prognosis. Type: Grant. Filed: July 18, 2013. Date of Patent: November 22, 2016. Assignee: Pain Therapeutics, Inc. Inventors: Hoau-Yan Wang, Lindsay Burns Barbier.

WebAug 29, 2024 · Cocrystal of tiotropium bromide and lac tose monohydrate . 58. US20240224724 . A1. ... prodrug and maleic acid cocrystal. US … WebMar 1, 2024 · Accounts of cocrystal investigations in the literature started in earnest in 2003 and patent applications soon followed. The frequency of both has steadily accelerated, demonstrating an enhanced understanding of the design, characterisation, and manufacture of cocrystals and heightened interest from industry.

Web6. The solid form of claim 1, which is a cocrystal. 7. The solid form of claim 6, wherein the cocrystal is anhydrous. 8. The solid form of claim 1 haying a DSC thermogram with a peak onset of approximately 146.4 C or a peak maximum at about 147.8 C. 9. The solid form of claim 8 haying a DSC thermogram which is substantially

WebEP-3954372-A1 chemical patent summary. EP-3954372-A1 chemical patent summary. National Institutes of Health. National Library of Medicine. National Center for Biotechnology Information. PubChem. About. Posts. Submit. Contact. Search PubChem. Apologies, we are having some trouble retrieving data from our servers... PUGVIEW FETCH ERROR: 403 ... la law officeWebThis review article focuses on the interaction among certain scientific, legal, and … helmhoutWebMar 23, 2024 · Description. New Empagliflozin cocrystal. The present invention provides a novel empagliflozin co-crystal with improved stability and water solubility, which are problems of empagliflozin. Cocrystals are rich in functional groups that can form hydrogen bonds such as O, OH, and N, or coformers with a difference in pKa of 3 or less and … helm honda trx 3WebThe combination vaisartan and sacubitril is marketed under the tradename Entresto ® in the form of film-coated tablets for the prevention of heart failure in patients with chronic heart failure. Entresto ® contains the drug combination in the form of a cocrystal consisting of vaisartan disodium, sacubitril monosodium and 2.5 molecules water. The cocrystal has … helmhout 10WebApr 12, 2012 · A cocrystal contg. the API and glutaric acid in a 1:1 mol. ratio was … helm hotel ilwaco waWebThis disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt, and/or hydrate, and/or cocrystal, and/or drug combination of the compound) that inhibit (e.g., antagonize) Stimulator of Interferon Genes (STING). Said chemical entities are useful, e.g., for treating a condition, disease or disorder in which … helmhout afbouwWebNov 23, 2012 · The article presents a legal discussion of patents and cocrystal patents in … helmhout losser